Humana alleges price fixing in lawsuit against generic drug makers

LOUISVILLE, Ky. — Humana filed a lawsuit Friday in the Eastern District of Pennsylvania, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs.

In the 610-page complaint, Humana says that it is seeking to recover damages incurred from paying overcharges for commonly used generics. Humana alleges that the defendants, including Actavis, Dr. Reddy’s Laboratories, Glenmark, Mylan, Sandoz, Sun, Teva and others, used secret communications at public and private events —including major trade association meetings — to orchestrate a scheme in which they fixed prices and rigged bids on drugs. For more on this story, please go to